ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1437

Journal of Clinical & Experimental Pathology received 1437 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Transforming pathology: Biotechnology as a positive feedback loop for the evolution of anatomical pathology

4th International Conference and Exhibition on Pathology

Punit Virk

ScientificTracks Abstracts-Workshop: J Clin Exp Pathol

DOI: 10.4172/2161-0681.S1.016

Abstract
Many are familiar with the Moore�??s law exponential curve of price performance of computing and the extension of its influence over the world, in general. This idea is rooted in the belief that machines will be smarter than the whole human race combined in 2045 and will possess the means to take over the future agenda of the world. Moore�??s law is muted in medicine due to regulatory and safety considerations. So what stimulates exponential change in pathology? What are the drivers and inhibitors? Are our digital pathology systems going to wake up someday soon and tell us they can do our work better than we can? Will they be right about that? How much of a pathologist does work can only be done by a human being? When does the permanent vacation for flesh and blood pathologists begin? We all have a stake in the answers to these questions which pathologists seem to have been reluctant to ask until now!
Biography
Punit Virk is currently in the final year of his Bachelor of Science degree at the University of Alberta. He is the founder and advisor to the University of Alberta�??s Partner�??s In Health chapter. His current research interests involve the exploration of genetic therapies for highly pathological, rare genetic diseases like Fibrodysplasia Ossificans Progressiva. He has sat on advisory committees for undergraduate biology textbook development and teaching and learning in Science.
Top